Articles Tagged With:
-
Overview of Newer Antiepileptic Drugs for Neuropathic Pain and Migraine
Shared pathophysiologic mechanisms for migraine, neuropathic pain, and epilepsy underscore the notion that antiepileptic drugs (AED) should be standard treatment for the former. Five new AEDs and their use in these nonepileptic painful disorders are summarized. -
Reader question: Under HIPAA, subjects do have rights to their results
Question: What rights to their research-related results do patients have? -
Disorders of Gait and Balance Classified
Martin and ONeill called attention to and commented upon a revised classification of higher-level gait disorders (HLGD) proposed by Liston and associates. -
Stem cell trials present novel issues for IRBs
The furor surrounding the derivation and collection of embryonic stem cells has eclipsed the many other ethical, legal, and social issues that should be examined before these therapies move from the laboratory to human clinical application, say researchers working at Johns Hopkins University in Baltimore. -
Biochemical Pathogenesis of Intractable Epilepsy Due to Mesial Temporal Sclerosis
The concept that epilepsy arises from an imbalance between excitatory and inhibitory influences in epileptogenic tissue has become fundamental to further investigations of the pathophysiology of this disorder. The primary observation motivating the study of Eid and colleagues is that glutamate levels are elevated in patients with mesial temporal sclerosis (MTS), perhaps the most common cause of medication-resistant epilepsy. -
Embryo research creates heated ethics debates
A debate that has become more heated in the 21st century is whether all embryonic research should be subject to human subject research protection and IRB review. -
Pharmacology Watch: Sinus and Allergy Health Partnership Releases New Guidelines for Treatment of Bacterial Rhinosinusitis
New guidelines for the treatment of bacterial rhinosinusitis were published in the January supplement of Otolaryngology-Head and Neck Surgery by the Sinus and Allergy Health Partnership. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch: Valacyclovir Reduces Genital Herpes Transmission
-
Full March 2004 Issue in PDF